Found 34 articles for: "Hyperpigmentation"
Fundamentals of Hyperpigmentation Disorders: Causes, Concerns, and Treatment Strategies, Particularly in Skin of Color Patients
October 2026 | Volume 25 | Issue 10 | Original Article | 926 | Copyright © October 2026
Background: Pigmentary disorders, including hyperpigmentation, are among the most common dermatologic diagnoses in individuals with skin of color (SOC), particularly individuals ...
Read MorePost-Inflammatory Hyperpigmentation in Skin of Color Patients With Atopic Dermatitis
October 2026 | Volume 25 | Issue 10 | Features | 975 | Copyright © October 2026
Assessing the Variability of Dermatologic Needs in American Indian/Alaskan Native Populations: A Single-Center Retrospective Analysis
October 2026 | Volume 25 | Issue 10 | Editorials | e59 | Copyright © October 2026
Efficacy and Tolerability of a Topical Pigment-Correcting Serum in Melasma and Postinflammatory Hyperpigmentation
July 2026 | Volume 25 | Issue 7 | Original Article | 596 | Copyright © July 2026
Background: Melasma and postinflammatory hyperpigmentation (PIH) are common disorders of hyperpigmentation of key aesthetic concern. This study assessed the efficacy and tolerabi...
Read More1927 nm Diode Laser for Infraorbital Hyperpigmentation in Skin of Color: Safe and Effective Approach
July 2026 | Volume 25 | Issue 7 | Features | 666 | Copyright © July 2026
Background: Infraorbital hyperpigmentation (IOH) is a common aesthetic concern with multifactorial pathogenesis, especially prevalent in patients with skin of color (SOC). Its ma...
Read MoreRacial Differences in Secondary Skin Complications and Timing of Topical Therapy Initiation for Pseudofolliculitis Barbae: A Multicenter Retrospective Database Cohort Study
July 2026 | Volume 25 | Issue 7 | Editorials | e69 | Copyright © July 2026
Public Interest in Hyperpigmentation: Insights From a Google Trends Analysis
July 2026 | Volume 25 | Issue 7 | Original Article | 629 | Copyright © July 2026
Background: Pigmentary disorders, particularly hyperpigmentation, disproportionately affect individuals with skin of color and are associated with significant psychosocial burden...
Read MoreA Novel Retinoid and Salicylic Acid Topical Treatment for Moderate-Severe Acne
June 2026 | Volume 25 | Issue 6 | Original Article | 558 | Copyright © June 2026
Background: Advances in biotechnology have enabled highly effective, site-specific topical therapies for skin disease. Particle-based delivery systems can be engineered with tail...
Read MoreIron Oxides in Tinted Sunscreen for Hyperpigmentation: A Product Analysis and Literature Review
May 2026 | Volume 25 | Issue 5 | Original Article | 440 | Copyright © May 2026
Background: Hyperpigmentation disproportionately affects skin of color, often exacerbated by visible light (VL) exposure. Photoprotection in these populations remains underused d...
Read MoreAn Investigator-Developed Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color
April 2026 | Volume 25 | Issue 4 | Original Article | 330 | Copyright © April 2026
Background: There is an unmet demand for a post-inflammatory hyperpigmentation (PIH) treatment and prevention that is not only effective and accessible, but also safe to use in d...
Read MoreHydroquinone and Emerging Depigmenting Agents: Clinical Guidelines, Regulatory History, and Global Safety Considerations
April 2026 | Volume 25 | Issue 4 | Original Article | 363 | Copyright © April 2026
Hydroquinone has long served as the gold standard for hyperpigmentation treatment, but safety concerns, regulatory changes, and growing interest in non-hydroquinone therapies have prompted reeval...
Read MoreRapid Clearance of Lichen Planus With Topical Tapinarof
April 2026 | Volume 25 | Issue 4 | Case Reports | 381 | Copyright © April 2026
Background: Lichen planus (LP) is an auto-inflammatory idiopathic condition affecting skin, mucous membranes, hair follicles, and nails that presents as pruritic, violaceous papu...
Read MoreEfficacy and Safety of Cysteamine-Isobionic Amide Complex in the Treatment of Periorbital Hyperpigmentation
February 2026 | Volume 25 | Issue 2 | Original Article | 140 | Copyright © February 2026
Periorbital hyperpigmentation is a common yet challenging cosmetic concern due to the thin, vascular, and pigment-prone nature of periocular skin, as well as its multifactorial etiology. Discolor...
Read MoreA Novel Topical Agent for the Management of Hyperpigmentation, Including Melasma and Age Spots
January 2026 | Volume 25 | Issue 1 | Original Article | 75 | Copyright © January 2026
Background/Objectives: Melasma and age spots are among the most persistent and difficult-to-treat forms of hyperpigmentation. While traditional therapies offer some clinical effi...
Read MoreEvaluation of an Advanced, Multimodal Skin Tone Correcting Serum in Participants With Mild-to-Severe Dyschromia and Hyperpigmentation
January 2026 | Volume 25 | Issue 1 | Original Article | 36 | Copyright © January 2026
Background: A new multimodal skin tone correcting serum formulated with b.r.y.t.e.r. (brown, red, and yellow tones with enhanced resurfacing) technology (EV-I) targets brown, red...
Read MoreClinical Evaluation of a Thiamidol-Based Regimen With SPF Compared With SPF Alone for Facial Hyperpigmentation
January 2026 | Volume 25 | Issue 1 | Original Article | 48 | Copyright © January 2026
Read MoreA Randomized, Controlled, Split-Face, Double-Blind Study Comparing Topical Malassezin to Hydroquinone 4% for Melasma
January 2026 | Volume 25 | Issue 1 | Original Article | 25 | Copyright © January 2026
Background: Previous studies have documented the capacity of malassezin to brighten the skin. It represents a novel agent for the treatment of hyperpigmentation.Photodistributed Hyperpigmentation Associated With COVID-19 Vaccination
January 2026 | Volume 25 | Issue 1 | Case Reports | 93 | Copyright © January 2026
Background: Although drugs are a common cause of hyperpigmentation, the pathogenesis is unclear and varies based on the offending agent. Classic medications associated with hyper...
Read MoreClinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation
December 2025 | Volume 24 | Issue 12 | Original Article | 1195 | Copyright © December 2025
Read MoreThe Impact of Hyperpigmentation on the Lives of Patients
July 2025 | Volume 24 | Issue 7 | Original Article | 668 | Copyright © July 2025
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
